Page last updated: 2024-08-22

technetium 99m and Prostatic Neoplasms

technetium 99m has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Duncan, I; Ingold, N; Martinez-Marroquin, E; Paterson, C	1

Other Studies

1 other study(ies) available for technetium 99m and Prostatic Neoplasms

Article	Year
An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy. The Prostate, 2023, Volume: 83, Issue:10 Topics: Australia; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Technetium; Tomography, Emission-Computed, Single-Photon	2023

Article

Year

An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy.

The Prostate, 2023, Volume: 83, Issue:10

Topics: Australia; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Technetium; Tomography, Emission-Computed, Single-Photon

2023